Jefferies Maintains Buy on Inovio Pharmaceuticals, Raises Price Target to $8
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice Target
Jefferies analyst Roger Song maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and raises the price target from $3 to $8.
Jefferies analyst Roger Song maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and raises the price target from $3 to $8.